AI assistant
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2008
Dec 16, 2008
33882_dirs_2008-12-16_7fcfa169-f627-4911-bc9a-6929fd1547e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2008-12-15
Reporting Person: VENTURES WEST CAPITAL LTD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-12-15 | Common Stock | S | 410587 | $5.95 | Disposed | 435056 | Indirect |
| 2008-12-15 | Common Stock | S | 39413 | $5.95 | Disposed | 41763 | Indirect |
Footnotes
F1: Shares are directly held by Ventures West 7 Limited Partnership, whose general partner is Ventures West 7 Management Ltd, an
entity wholly owned by Ventures West Capital Ltd. and whose officers are similar to the officers of Ventures West Capital
Ltd.
F2: Shares are directly held by Ventures West 7 U.S. Limited Partnership, whose manager is Ventures West 7 Management
(International) Inc., an entity controlled by Ventures West Capital Ltd.
F3: Ventures West Capital, Ltd., the Designated Filer, controls the general partner of Ventures West 7 Limited Partnership (whose
general partner is Ventures West 7 Management Ltd.) and controls the manager of Ventures West 7 U.S. Limited Partnership
(whose manager is Ventures West 7 Management (International) Inc.).